Let me know when the data is updated again

MEDICAMENTOS PATENTE

CONTRACT SUMMARY AA-019GYR047-E80-2017-1674985

Total amount

624 millones de pesos mexicanos (624,030,070.6 MXN)

Contract period(s)

Between 1 de enero de 2018 and 31 de diciembre de 2018

Proveedor(es)

FARMACEUTICOS MAYPO, S.A. DE C.V. (RFC: FMA9301181B1) from México

This contract is part of a record. See record ocds-0ud2q6-AA-019GYR047-E80-2017 in Open Contracting Data Standard format.

CONTRACT QUALITY

More than 20 algorithmic tests are run at the contract level, grouped into four categories, to determine the quality of procurement data. The methodology can be consulted here.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

This contract has not been evaluated.

PLANNING

CALL FOR TENDERS

Call type

Adjudicación Directa Federal (direct)

Regulations: 05. Adjudicación Directa LAASSP

Scope

Internacional bajo TLC

Purchase type

Adquisiciones (goods)

Submission methods:

inPerson

Call period:

26 de diciembre de 2017 - 21 de diciembre de 2017

Call status

complete

AWARD AND CONTRACT

Call title

AA-019GYR047-E80-2017 MEDICAMENTOS PATENTES

Award title

MEDICAMENTOS PATENTE

Contract title

MEDICAMENTOS PATENTE

Supplier(s)

FARMACEUTICOS MAYPO, S.A. DE C.V. (RFC: FMA9301181B1)

Amount

624 millones de pesos mexicanos (624,030,070.6 MXN)

Execution period

1 de enero de 2018 to 31 de diciembre de 2018

Internal award code

1674985

This contract is Expirado (terminated) . The contract term has ended.

IMPLEMENTATION

No data

GENERAL INFORMATION

Date updated in QQW

11 de septiembre de 2019

Part of the project

TodosLosContratos.mx

Organization responsible for the import

PODER